Review Article
Volume 10 Issue 2 - 2021
Neurolinguistic Programming in Practice: More Empirical than Magical
Nicholas A Kerna1,2*, Uzoamaka Nwokorie3, Abdullah Hafid4, Kevin D Pruitt5, Michael J DelGiodice6, Oluwatosin A Atolagbe7, Ijeoma Nnake2, Hilary M Holets8,9 and Fernand Jean-Baptiste10
1SMC–Medical Research, Thailand
2First InterHealth Group, Thailand
3University of Washington, USA
4Academy of Integrative Health and Medicine (AIHM), USA
5Kemet Medical Consultants, USA
6Associated Eye Physicians, USA
7Zorvis Inc., USA
8Beverly Hills Wellness Surgical Institute, USA
9Orange Partners Surgicenter, USA
10Department of Biological Sciences, Florida Atlantic University, USA
*Corresponding Author: Nicholas A Kerna, (mailing address) POB47 Phatphong, Suriwongse Road, Bangkok, Thailand 10500.
Received: February 25, 2021; Published: February 27, 2021


In essence, neurolinguistic programming (NLP) is a psychotherapeutic approach, applying understanding and reformation of thinking and behavior for specific psychological and physical conditions. NLP differs from psychotherapies, such as hypnotherapy, counseling and cognitive-behavioral therapy, in that NLP aims to alter the underlying thought pattern, eliminating the hindrance. Whether or not NLP should be merged with mainstream medical practice is a matter of ongoing debate. Nevertheless, the practice of NLP leads to useful communication and rapport building between doctors and patients. It remains challenging to determine the efficacy of NLP as singular therapy or combined therapy via classical research studies into such subjective matters as fear, pain, and depression. However, for many patients, NLP simply “works”.

This review is designed as a practical resource regarding NLP. It begins with a historical background (notable researchers and studies), reviews evidence-based research, presents indications and contraindications, highlights applications in specific conditions, such as: phobias (panic and anxiety disorders, claustrophobia, and acrophobia); post-traumatic depression and anxiety (injury, stroke, disability, and death); occupational stress; chronic pain; pregnancy; substance abuse; application and integration in medical practice; and training and certification. The design was to develop a succinct—go-to—resource for physicians, psychologists, health care providers, policymakers, and the general public.

Keywords: Addiction; Depression; Pain Relief; Phobia; Post-Traumatic; Psychotherapy; Sports Injury, Stress; Substance Abuse


  1. Sturt J., et al. “Neurolinguistic programming: A systematic review of the effects on health outcomes”. British Journal of General Practice 604 (2012): 656-664.
  2. Canadian Agency for Drugs and Technologies in Health. Neuro-Linguistic Programming for the Treatment of Adults with Post-Traumatic Stress Disorder, General Anxiety Disorder, or Depression: A Review of Clinical Effectiveness and Guidelines”. Canadian Agency for Drugs and Technologies in Health (2014).
  3. Lewis Walker. Changing with NLP. “A Casebook of Neuro-linguistic Programming in Medical”. Google Books (2021).
  4. Joseph O’Connor and John Seymour. “Introducing NLP: Psychological Skills for Understanding and Influencing People”. Thorsons (1993).
  5. Zaharia C., et al. “Evidence-Based Neuro Linguistic Psychotherapy: A Meta-Analysis 27 (2015).
  6. Heap M. “The Validity Of Some Early Claims Of Neuro-Linguistic Programming 11 (2008).
  7. Bandler R and Grinder J. “The Structure Of Magic I A Book about Language and Therapy” (1975).
  8. Karunaratne M. “Neuro-linguistic programming and application in treatment of phobias”. Complementary Therapies in Clinical Practice4 (2010): 203-207.
  9. Shlomo Vaknin. “NLP for Beginners: Only the Essentials”. Inner Patch Publishing (2009).
  10. Kudliskis V. “Neuro-linguistic programming and altered states: encouraging preparation for learning in the classroom for students with special educational needs”. British Journal of Special Education2 (2013): 86-95.
  11. Wiseman R., et al. “The Eyes Don't Have It: Lie Detection and Neuro-Linguistic Programming. Lappe M, ed”. PLoS ONE7 (2012): e40259.
  12. Stipancic M., et al. “Effects of Neuro-Linguistic Psychotherapy on psychological difficulties and perceived quality of life”. Counselling and Psychotherapy Research 1 (2010): 39-49.
  13. Frogs into princes: neuro linguistic programming / by Richard Bandler and John Grinder; edited by ... | National Library of Australia (2021).
  14. Gray RM and Liotta RF. “PTSD: Extinction, reconsolidation, and the visual-kinesthetic dissociation protocol”. Traumatology 2 (2012): 3-16.
  15. Daniel D and John AS. “Enhancing human performance: Issues, theories, and techniques”. Human Resource Development Quarterly2 (1988): 202-206.
  16. Zastrow C. “Social Workers and Sales workers”. Journal of Independent Social Work3 (1990): 7-16.
  17. Yemm G. “Can NLP help or harm your business?” Industrial and Commercial Training1 (2006): 12-17.
  18. Grosu VT., et al. “Neurolinguistic programming techniques in sports training for enhancing performance capacity”. Palestrica of the third millennium ‒ Civilization and Sport3 (2013): 212-218.
  19. Pensieri C. “Neurolinguistic programming in health: An analysis of the literature”. Methodology and Education for Clinical Innovation2 (2013): 97-105.
  20. Brown TC and Latham GP. “Maintaining relevance and rigor: How we bridge the practitioner-scholar divide within human resource development”. Human Resource Development Quarterly2 (2018): 99-105.
  21. Dilts R. “Applications of Neuro-Linguistic Programming”. Meta Publ., Cop (1983).
  22. Witkowski T. “Thirty-Five Years of Research on Neuro-Linguistic Programming. NLP Research Data Base. State of the Art or Pseudoscientific Decoration?” Polish Psychological Bulletin2 (2010).
  23. Grimley BN. “What is NLP? The development of a grounded theory of neurolinguistic programming, (NLP), within an action research journey. Implications for the use of NLP in coaching psychology”. International Coaching Psychology Review2 (2016): 166-178.
  24. Kessler RC., et al. “Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication”. Archives of General Psychiatry6 (2005): 617-627.
  25. Krugman M., et al. “Neuro-linguistic programming treatment for anxiety: Magic or myth?” Journal of Consulting and Clinical Psychology4 (1985): 526-530.
  26. Simpson SDR and Dryden W. “Comparison between REBT and Visual/Kinaesthetic Dissociation in the Treatment of Panic Disorder: An Empirical Study”. Journal of Rational - Emotive and Cognitive - Behavior Therapy3 (2011): 158-176.
  27. Einspruch EL and Forman BD. “Neuro-linguistic programming in the treatment of phobias”. Psychotherapy in Private Practice1 (1988): 91-100.
  28. Konefal J and Duncan RC. “Social anxiety and training in neurolinguistic programming”. Psychological Reports3-1 (1998): 1115-1122.
  29. Bigley J., et al. “Neurolinguistic programming used to reduce the need for anaesthesia in claustrophobic patients undergoing MRI”. British Journal of Radiology986 (2010): 113-117.
  30. Arroll B., et al. “A systematic review and meta-analysis of treatments for acrophobia”. Medical Journal of Australia6 (2017): 263-267.
  31. An Investigation Of The Effectiveness Of Neurolinguistic Programming Procedures In Treating Snake Phobics (2021).
  32. Peng Y., et al. “The Effect of a Brief Intervention for Patients with Ischemic Stroke: A Randomized Controlled Trial”. Journal of Stroke and Cerebrovascular Diseases8 (2015): 1793-1802.
  33. Savardelavar M and Kuan G. “The Use of Neuro-Linguistic Programming as an Educational-Therapeutic Programme: Two Case Studies”. Education in Medicine Journal1 (2017): 49-58.
  34. Wake L and Leighton M. “Pilot study using neurolinguistic programming (NLP) in post-combat PTSD”. Mental Health Review Journal4 (2014): 251-264.
  35. Mohamad FA. “Pediatric Nurses' Stresses in Intensive Care Units and its Related Factors (2021).
  36. HemmatiMaslakpak M., et al. “The effect of neuro-linguistic programming on occupational stress in critical care nurses”. Iranian Journal of Nursing and Midwifery Research1 (2016): 38.
  37. Bolstad R and Prochazka L. “NLP and relief of chronic pain”. Anchor Point Magazine 17 (2003): 1.
  38. Wheatley D. “Treatment of pregnancy sickness”. BJOG: An International Journal of Obstetrics and Gynaecology6 (1977): 444-447.
  39. Gray RM. “The Brooklyn Program - Innovative Approaches to Substance Abuse Treatment”. Federal Probation (2002): 66.
  40. King M., et al. “Irresistible Communication: Creative Skills for the Health Professional”. Saunders (1983).
  41. Christensen JF., et al. “Applications of neurolinguistic programming to medicine”. Journal of General Internal Medicine 6 (1990): 522-527.
  42. McDonnell D. “Time for NLP to be part of mainstream GP consultation teaching?” British Journal of General Practice 624 (2014): 363.
Citation: Kerna NA, Nwokorie U, Hafid A, Pruitt KD, DelGiodice MJ, Atolagbe OA, Nnake I, Holets HM, Jean-Baptiste F. “Neurolinguistic Programming in Practice: More Empirical than Magical”. EC Psychology and Psychiatry 10.4 (2021): 00-00.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

May Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the May issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before May 21, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to